Characterization of transcriptome diversity and in vitro behavior of primary human high-risk breast cells
Alothman, Sahar J., Kang, Keunsoo, Liu, Xuefeng, Krawczyk, Ewa, Azhar, Redha I., Hu, Rong, Goerlitz, David, Kallakury, Bhaskar V., Furth, Priscilla A.
Published in Scientific reports (22.04.2022)
Published in Scientific reports (22.04.2022)
Get full text
Journal Article
Abstract 656: Histological and 3D morphological evaluation of mammary cancers and primary cells from genetically engineered mice with only one copy of Brca1 disrupted in combination with Trp53 haploinsufficiency
Alothman, Sahar J., Wang, Weisheng, Kallakury, Bhaskar V., Furth, Priscilla
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
Differential efatutazone's impact on mammary neoplasia dependent upon Brca1 dose
Alothman, Sahar J, Wang, Weisheng, Chao, Shan, Kallakury, Bhaskar V, Díaz-Cruz, Edgar S, Furth, Priscilla A
Published in Endocrine-related cancer (01.12.2018)
Published in Endocrine-related cancer (01.12.2018)
Get full text
Journal Article
Responsiveness of Brca1 and Trp53 Deficiency-Induced Mammary Preneoplasia to Selective Estrogen Modulators versus an Aromatase Inhibitor in Mus musculus
Alothman, Sahar J, Wang, Weisheng, Goerlitz, David S, Islam, Md, Zhong, Xiaogang, Kishore, Archana, Azhar, Redha I, Kallakury, Bhaskar V, Furth, Priscilla A
Published in Cancer prevention research (Philadelphia, Pa.) (01.04.2017)
Published in Cancer prevention research (Philadelphia, Pa.) (01.04.2017)
Get full text
Journal Article
Abstract 5576: Tamoxifen fails to induce regression of mammary preneoplasia in mice lacking either one or two intact BRCA1 genes in combination with p53 haploinsufficiency but without evidence of in vivo agonist activity
Alothman, Sahar J., Wang, Weisheng, Furth, Priscilla A.
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article